Lion Street Advisors’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461K | Buy |
340,025
+6,300
| +2% | +$8.54K | 0.14% | 158 |
|
|
2025
Q1 | $318K | Buy |
333,725
+26,059
| +8% | +$24.8K | 0.1% | 197 |
|
|
2024
Q4 | $396K | Buy |
307,666
+34,385
| +13% | +$44.2K | 0.13% | 164 |
|
|
2024
Q3 | $544K | Buy |
273,281
+20,000
| +8% | +$39.8K | 0.19% | 120 |
|
|
2024
Q2 | $505K | Buy |
253,281
+60,581
| +31% | +$121K | 0.19% | 116 |
|
|
2024
Q1 | $161K | Hold |
192,700
| – | – | 0.07% | 247 |
|
|
2023
Q4 | $161K | Buy |
+192,700
| New | +$161K | 0.07% | 246 |
|